Bentley R Olson Etches, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13231 Jones St, Lavonia, GA 30553 Phone: 706-356-1333 Fax: 706-356-1433 |
Jonathan Hugh Weathers, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13231 Jones St, Lavonia, GA 30553 Phone: 706-356-1333 Fax: 706-356-1433 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.
Last year, researchers from the Perelman School of Medicine at the University of Pennsylvania found that small amounts of a misfolded brain protein can be taken up by healthy neurons, replicating within them to cause neurodegeneration. The protein, alpha-synuclein (a-syn), is commonly found in the brain, but forms characteristic clumps called Lewy bodies, in neurons of patients with Parkinson's disease (PD) and other neurodegenerative disorders.
An investigation led by a team of researchers from the Massachusetts General Hospital departments of Neurology, Psychiatry and Radiology has found altered connectivity among brain regions that handle sensorimotor, emotional and cognitive signaling in patients with functional neurological disorder, a common condition involving neurologic symptoms that have no readily apparent physical cause.
Macrophages are cellular sentinels in the body, assigned to identify "attacks" from viruses, bacteria, or fungi and sound the alarm when they are present. However, these cells are a "double edged sword" in spinal cord injury, providing both neural repair-promoting properties and pathological functions that destroy neuronal tissue
A $375,000 grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation was awarded to Subramanian Dhandayuthapani, Ph.D., an associate professor in the Center of Emphasis in Infectious Diseases at the Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, to develop genetically altered vaccines against tuberculosis (TB).
› Verified 3 days ago